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ABSTRACT: Tandem mass spectrometry (MS/MS or MS2) is a widely used approach for structural annotation and
identiﬁcation of metabolites in complex biological samples. The importance of assessing the contribution of the precursor ion
within an isolation window for MS2 experiments has been previously detailed in proteomics, where precursor ion purity
inﬂuences the quality and accuracy of matching to mass spectral libraries, but to date, there has been little attention to this data-
processing technique in metabolomics. Here, we present msPurity, a vendor-independent R package for liquid chromatography
(LC) and direct infusion (DI) MS2 that calculates a simple metric to describe the contribution of the selected precursor. The
precursor purity metric is calculated as “intensity of a selected precursor divided by the summed intensity of the isolation
window”. The metric is interpolated at the recorded point of MS2 acquisition using bordering full-scan spectra. Isotopic peaks of
the selected precursor can be removed, and low abundance peaks that are believed to have limited contribution to the resulting
MS2 spectra are removed. Additionally, the isolation eﬃciency of the mass spectrometer can be taken into account. The package
was applied to Data Dependent Acquisition (DDA)-based MS2 metabolomics data sets derived from three metabolomics data
repositories. For the 10 LC-MS2 DDA data sets with > ±1 Da isolation windows, the median precursor purity score ranged from
0.67 to 0.96 (scale = 0 to +1). The R package was also used to assess precursor purity of theoretical isolation windows from LC-
MS data sets of diﬀering sample types. The theoretical isolation windows being the same width used for an anticipated DDA
experiment (±0.5 Da). The most complex sample had a median precursor purity score of 0.46 for the 64,498 XCMS determined
features, in comparison to the less spectrally complex sample that had a purity score of 0.66 for 5071 XCMS features. It has been
previously reported in proteomics that a purity score of <0.5 can produce unreliable spectra matching results. With this
assumption, we show that for complex samples there will be a large number of metabolites where traditional DDA approaches
will struggle to provide reliable annotations or accurate matches to mass spectral libraries.
Mass spectrometry (MS) is routinely used to (semi)-quantify, annotate, and identify small molecules
(metabolites) in complex biological matrices. An MS
experimental workﬂow can consist of infusing a sample directly
into a mass spectrometer without any prior chromatographic
separation (direct infusion mass spectrometry; DIMS),1 but
more often, the sample components are spatially separated via
either gas or liquid chromatography (LC).2 The predictable
mass fragmentation patterns observed from the electron
ionization (EI) technique commonly used with gas chromatog-
raphy allows for reliable matching to mass spectral libraries
such as NIST3 and the Golm Metabolome Database.4 So-called
soft ionization techniques, including electrospray ionization
(ESI), used in conjunction with LC methods provide minimal
fragmentation because of the ionization process. In these cases,
gas-phase fragmentation can be applied through collision-
induced dissociation in hybrid quadrupole, ion trap, quadrupole
time-of-ﬂight (Q-TOF), or Orbitrap systems. The term
“tandem mass spectrometry” (MS/MS or MS2) is used when
a single collision step is used, but product ions can be isolated
for further collision to provide MSn spectra where n ≥ 3. The
focus of this paper is on fragmentation resulting from tandem
mass spectrometry.
A key component of any MS2 (or higher) technology is the
isolation of selected m/z windows for gas-phase fragmentation
and the mapping back of the fragmentation (product) spectrum
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to the selected m/z window. In targeted and data-dependent
acquisition (DDA)-based experiments, where MS2 is performed
on a dynamic list of precursor ions, as often determined by a
preceding MS full scan, an isolation window is centered on the
targeted precursor peak (m/z value). However, the isolation
window can often contain more than one distinct peak,
fragmentation spectra resulting from these situations being
termed “chimeric”5 and can be problematic for interpretation of
the spectra and mass spectral library searching.
The more conservative estimates of chimeric spectra in
proteomic DDA-based research are calculated as over 11.2% of
all MS2 spectra acquired,6 but others have calculated this to be
as high as 50% or more.5,7 A direct comparison between
diﬀerent studies is diﬃcult though as the number of chimeric
spectra will vary considerably based upon sample complexity,
instrumental conﬁguration, and the procedure by which
spectral chimerism is calculated.
The impact of chimeric spectra on spectral matching and
annotation depends on the purity of the isolation window
fragmented (i.e., the ratio between the relative intensity of the
precursor divided by the summed intensity of all ions within the
isolation window). If the purity of the precursor ion is
suﬃciently low, it can often be diﬃcult to determine the origin
of the resulting product ion(s). This in turn can lead to
erroneous spectral matching results or no spectral matches.
Deconvolution of chimeric spectra however is possible and
forms the basis of the data-analysis procedures applied to data
independent acquisition (DIA) experiments. Where previous
approaches in proteomics relied on comparison of fragmenta-
tion spectra to in silico-generated peptide databases,8 alternative
approaches have been derived from selected reaction
monitoring data analysis methods (MS-SWATH,9 Open-
SWATH10). Although not as prevalent as DDA-based analyses,
DIA-based approaches are also available in the ﬁeld of
metabolomics (MS-DIAL11).
A metabolomics analytical and data analysis workﬂow that
directly takes into consideration the purity of an isolation
window has also been developed, enabling deconvolution of
MS2 spectra.12 The approach, demonstrated using an Agilent
6520 Q-TOF instrument, requires sliding isolation windows to
be acquired surrounding the precursor of interest.
However, standard DDA-based approaches are still widely
used and are popular in metabolomics,13−15 and the
deconvolution techniques detailed above are not always
applicable to standard DDA-based acquisition techniques. In
these cases, simply assessing the targeted precursor purity can
be useful in interpreting the MS2 spectra and aid in assessing
the reliability of any subsequent annotation.
Some of the ﬁrst software that had the functionality to count
the number of chimeric spectra included the C/C++ software
“hardklör”6 and the python software “ChimeraCounter”.5
ChimeraCounter uses the “percent chimera intensity (PCI)”
metric to count chimeric spectra when peaks that are not
isotopes of the targeted precursor are within the isolation
window and are above a user-deﬁned percentage of the peak
height of the precursor. Another metric has been previously
described to calculate the “Precursor Ion Fragment” (PIF).16
This is calculated as the targeted precursor ion intensity divided
by the overall intensity in the isolation window and essentially
gives a score of the purity of the precursor at the closest full
scan (MS1) to the MS2 scan. The PIF implementation is
provided within the quantitative proteomics software package
MaxQuant.17
An automated computational method is detailed here to
calculate the purity of fragmentation spectra post-acquisition
from either a LC-MS2 or DIMS2 metabolomics experiment.
What we call here “precursor purity” is calculated with a revised
Michalski approach.16 Advances include that the metric is
interpolated at the recorded time of the MS2 acquisition using
bordering full scan spectra, the isolation eﬃciency of the mass
spectrometer can be included within the calculation, and as per
the PCI approach, isotopic peaks of the targeted precursor can
be removed and peaks with intensities below a minimum
percentage of the precursor peak intensity are removed from
the calculation. The software has been applied to investigate 12
DDA and one DIA metabolomics data sets for diﬀerent
biological samples retrieved from the data repositories
MetaboLights,18 Metabolomics Workbench,19 and PRIMe
Data Resource of Plant Metabolomics (DROP Met) (http://
prime.psc.riken.jp/). We also detail how theoretical isolation
windows can be assessed using MS1 data sets collected
independent of MS2 acquisitions. The computational methods
detailed in this paper are available in the R package “msPurity”.
The package has been developed to work as a standalone or to
be used in conjunction with the metabolomics peak detection
and processing R package XCMS.20
■ MATERIALS AND METHODS
Overview of Software. An R package has been developed
to assess the contribution of the targeted precursor in a
fragmentation isolation window using a metric called “precursor
purity”. The use cases of the package can be divided into two
types:
1. Assessing precursor purity of previously acquired MS2
spectra: A user has acquired either LC-MS2 or DIMS2
spectra and an assessment is made of the precursor purity
for each MS2 scan.
2. Assessing precursor purity of anticipated isolation
windows for MS2 spectra: A user has acquired either
LC-MS or DIMS full scan (MS1) data and an assessment
is to be made of the precursor purity of detected features
using anticipated or theoretical isolation windows. This
information can then be used to guide further targeted
MS2 experiments.
Availability. The msPurity package is available for Windows
(both 32 and 64 bit), Mac OS, and Linux from the
Bioinformatics software repository for R: Bioconductor ≥ 3.4.
The code can also be downloaded directly from Github:
https://github.com/Viant-Metabolomics/msPurity.
File Preparation. The input for the msPurity R package
requires the raw vendor format of the mass spectrometry data
to be converted into the mzML ﬁle format.21 The controlled
vocabulary used for the mzML format allows the isolation
window widths used by the instrument to be parsed out of the
mzML ﬁle from either Thermo, Agilent, AB Sciex, or Waters
instruments. The conversion of instrument raw ﬁles to mzML
can be achieved with the Proteowizard conversion tool
MSconvert22 or RawConvertor.23
If spectra were not collected in centroid mode, it is essential
that the peaks are converted from proﬁle to centroid format
before processing within msPurity.
Assessing Purity of Acquired MS2 Spectra. To assess
the precursor purity of a MS2 data set, the m/z value of the
precursor ion associated with each MS2 spectrum must ﬁrst be
determined. With the assumption that the most abundant peak
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in the window will have the highest contribution to the
fragmentation spectrum, the most abundant peak within the
isolation window is used to deﬁne the precursor m/z value.
This is determined for the MS1 scan closest to the MS2 scan.
The precursor purity score of the targeted precursor ion is
then calculated directly from the mzML spectra of the MS1 scan
as “target precursor intensity/summed intensity in isolation
window”. This simple ratio provides an easy to interpret score
bounded between 0 and 1. A value of 1 should signify only the
selected precursor has contributed to the resulting spectra, and
values closer to 0 should signify that there is little or no
contribution from the selected precursor ion to the summed
intensity in the isolation window. It should be noted that this
approach is unable to distinguish isobaric species.
It is not possible to calculate the score at the exact time of
the MS2 acquisition as the MS1 spectra is typically not acquired
simultaneously for DDA approaches. To account for this, the
precursor purity is calculated using two MS1 scans, one prior to
and one post MS2 acquisition, then interpolated at the point of
MS2 acquisition (Figure 1).
Assessing Purity of Anticipated Isolation Windows for
MS2 Spectra. The precursor purity calculation is performed
using information derived solely from the MS1 spectra;
therefore, the calculation can be performed independently
from any MS2 acquisition.
The steps for assessing the precursor ion purity of anticipated
MS2 spectra using an LC-MS data set are as follows:
1. Feature detection is carried out within XCMS.
2. The full width half-maximum (fwhm) of the chromato-
graphic peak is calculated for each XCMS feature.
3. The median precursor purity score (intensity of target/
summed intensity in anticipated isolation window) is
then calculated for the fwhm of the chromatographic
peak of each feature (Figure 2). The median score is then
calculated across any chosen samples or technical
replicates.
The steps for assessing the precursor purity of anticipated
MS2 spectra using DIMS data sets consists of the following:
1. Basic processing centroid peaks performed within
msPurity. This involves ﬁltering out peaks below a user
determined signal-to-noise level, averaging between
multiple scans, ﬁltering peaks not present in a minimum
number of scans, ﬁltering of peaks where the relative
standard deviation of the intensity is below a given
threshold, and removal of blank peaks from the sample
peak list.
2. The median precursor purity score is determined for
each feature across all scans in the data set.
The predicted purity scores can be used to select features for
MS2 in a targeted or semi-targeted experiment, e.g., using a
“nearline” approach.24 Additionally, the information can be
Figure 1. Assessment of acquired MS2 precursor purity for a standard DDA-based experiment. Scans 1 and 6 are MS1 scans, and scans 2 to 5 are MS2
scans for diﬀerent selected precursor ions where a DDA top 4 method (fragment the top 4 most intense ions) has been applied. The example in the
ﬁgure calculates the precursor purity for scan 3. The precursor purity is calculated prior to the MS2 acquisition (1) and after MS2 acquisition (2), and
the ﬁnal score is then interpolated at the time of the MS2 acquisition using bordering full-scan spectra (3).
Figure 2. Assessing precursor purity of anticipated isolation windows
for two XCMS features derived from a MS2 data set. The extracted ion
chromatogram (EIC) of each feature (red) and the intensity of
contaminating peaks (blue) within a ±0.5 Da window are shown, scan
range determined by XCMS, approximate full width half-maximum
(fwhm) highlighted with red vertical lines.
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used to assess what isolation window width would be suitable
for any subsequent MS2 experiments.
Removal of Isotopic Peaks. The msPurity package can
determine if the 13C isotopic peak of the targeted precursor is
within the isolation window or if the targeted precursor is the
13C isotopic peak. This is performed for single, doubly, and
triply charged species and applies the m/z diﬀerence (1.0033,
0.5017, and 0.3344, respectively) to identify the 13C isotopic
peaks. The isotopic related peak that is not the precursor can
then be omitted from any of the purity calculations. See
Supporting Information, Section 1, for further details. Whether
or not isotopic peaks are to be removed should depend on the
downstream analysis to be performed; for consistency, all
results shown in the paper do not omit the isotopic peaks from
the purity calculations.
Removal of Peaks of Relative Low Abundance. When
using larger isolation windows, there can often be numerous
peaks that have a low intensity relative to the targeted precursor
peak and that have little impact on the product ion
fragmentation spectrum. When these peaks are included in
the purity calculation, a lower precursor purity score can be
calculated, which is misleading. To accommodate for this, only
peaks that have an intensity greater than 5% of the targeted
precursor ion peak are included in the precursor purity
calculation (the threshold of 5% can be adjusted by the
user). A similar approach is used in the PCI calculation.5
Isolation Eﬃciency. Isolation eﬃciency is deﬁned here as
the eﬀect of the position of an ion within an isolation window
on its relative intensity in corresponding fragmentation spectra.
When the isolation eﬃciency of an instrument is known, the
peak intensities within an isolation window can be normalized
for the precursor purity calculation.
The isolation eﬃciency can be estimated experimentally by
acquiring MS2 spectra where the precursor ion of interest is
experimentally measured at diﬀerent locations within the
isolation window. The precursor ion peak, or a known product
ion peak, can then be monitored across the isolation window.
The resulting intensity proﬁle is then converted to be within a
scale of 0 to 1, where 1 is the position in the isolation window
with highest response and 0 is where the precursor ion is not
detected. This eﬃciency proﬁle can then be used to normalize
the peak intensities based on their position within the isolation
window.
For this study, the isolation eﬃciency experiment was
performed using a Thermo Scientiﬁc Q Exactive Focus mass
spectrometer operated with a ±0.5 Da isolation window.
Isolated ions had m/z values of 195.0875, 524.2649, and
922.0086 and were generated from constituents of a Pierce
LTQ Velos ESI positive ion calibration solution (product
number #88323). The mean isolation eﬃciency proﬁle was
then used to create a simple linear model using B-spline
polynomials (ﬁve anchors) to predict the isolation eﬃciency
based on isolation window position (adjusted R2: 0.9812; F:
210; p-value < 0.001) (Figure 3).
In addition, an assessment of isolation windows for Waters
instruments was also carried out using a Xevo G2 XS QTOF
mass spectrometer tuned to a mass resolution of 40,000 and
run in positive ESI mode. When operated in MS2 mode, the
quadrupole low mass resolution was manually tuned to 23
providing a ±0.5 Da isolation window. Isolation windows
surrounding ions at m/z 269.20, 362.95, and 906.81 from a
solution of 0.5 mM sodium formate in 90:10 isopropanol:water
were assessed. The mean isolation eﬃciency proﬁle observed is
similar in shape to a Gaussian curve (Figure S1)
Public Metabolomic Data Sets. A total of 12 DDA and
one DIA data sets were obtained from the public data
repositories MetaboLights,18 Metabolomics Workbench,19 and
PRIMe Data Resource of Plant Metabolomics (DROP Met)
(http://prime.psc.riken.jp/) to be assessed for their precursor
purity. See Table S2 for a summary of the studies. As of
December 31, 2015, this is an exhaustive list of DDA and DIA
data sets that include either the RAW, mzML, or other XML
open source data formats. Further details of the experimental
setup for each study can be located in the corresponding
submission entry on the relevant data repository web site and
within the associated papers for each study.
If not already in a mzML centroided data format, the ﬁles
were converted using Proteowizard MSconvert (v3.0).22 The
purity assessments were made for all MS2 scans for every
sample using the msPurity package using the function “purityA”
with standard parameter settings. Importantly though, the
precursor purity was calculated for all studies using the most
intense peak within the isolation window as the target precursor
ion, isotopic peaks were not removed, and no isolation
eﬃciency normalization was performed. The eﬃciency normal-
ization was omitted from the public data as it was not possible
to retrospectively produce comparable isolation eﬃciency
proﬁles for the multiple instruments used.
If possible, the isolation window widths were extracted from
the mzML ﬁle. However, for data sets derived from the Agilent
Q-TOF, the isolation window widths are not included in the
mzML ﬁle. For Agilent Q-TOF instrumentation, the isolation
windows are determined as either narrow (≈1.3 amu), medium
(≈4 amu), or large (≈9 amu), with the exact widths changing
Figure 3. Overview of isolation eﬃciency experiment determined
using a Thermo Scientiﬁc Q Exactive Focus. (A) Isolation eﬃciency
proﬁle of Thermo Scientiﬁc Q Exactive Focus mass spectrometer on
the following ions: 195.0875, 524.2649, and 922.0086 m/z. (B) A
simple linear model using B-spline polynomials to predict isolation
eﬃciency based on isolation window position for the Thermo
Scientiﬁc Q Exactive Focus mass spectrometer (negative values have
been zeroed).
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depending on the instrument. In the case of the Agilent data
sets used here (ST000075 and ST000085), a narrow resolution
of ≈1.3 amu was used. For these ﬁles, an approximate isolation
window of ±0.65 Da centered on the precursor ion m/z was
used for the purity assessments. For Agilent Q-TOF instru-
ments, the medium and large window widths are not currently
supported within msPurity, as these larger isolation window
widths are not evenly centered on the recorded precursor m/z
in the mzML ﬁle.
In-House Metabolomic Data Sets. Two LC-MS metab-
olomic data sets were acquired to assess XCMS-derived
metabolite features for precursor purity.
Daphnia magna extract (using 2.5:1 v/v methanol:water) was
separated using a reversed-phase Syncronis Phenyl LC column,
and mass spectral detection of the LC column eluates was
performed using a Thermo Scientiﬁc Q Exactive mass
spectrometer equipped with a H-ESI II source acquiring in
positive ionization mode.
Additionally, Ovis aries (sheep) kidney tissue extracts (using
70/30 methanol/water) were separated using a Hypersil Gold
C18 reversed phase column and analyzed using a Thermo
Scientiﬁc Q Exactive Focus mass spectrometer. Feature
detection was carried out using the XCMS package20 with
the following parameters: peak picking algorithm = centWave,
snthrs = 5, ppm = 5, preﬁlter = c(3, 5000), integrate = 1, and
mzdiﬀ = 0.001. Peaks were aligned by retention time using the
retcor.loess algorithm and grouped using the group.density
algorithm with the following settings: bw = 5, mzwid = 0.01,
and minfrac = 0.5. The msPurity function “purityX” was run on
the xcmsSet objects to assess the precursor purity of theoretical
isolation windows of ±0.5 Da for XCMS features using the
isolation eﬃciency normalization predicted for the Thermo
Fisher Q Exactive mass spectrometer. See Supporting
Figure 4. Overview of assessment of precursor purity for public DDA and DIA metabolomic data sets. (A) Boxplots of calculated purity scores of all
fragmentation spectra. See Figure S2 for violin plots derived from the same data. (B) Summary of purity score relationship with selected precursor
intensity and m/z value for study MTBLS144; x axis is in log10 scale. (C) The mean purity relationship with the distance from the preceding MS1
scan for study MTBLS214. Error bars represent one standard error of the mean.
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Information, Section 3, for a more extensive description of the
materials and methods for the in-house metabolomics data sets.
■ RESULTS AND DISCUSSION
Assessment of Precursor Ion Purity for Publically
Available DDA and DIA Data Sets. Figure 4 and Table 1
summarize the purity of available LC-MS and DIMS-based
DDA data sets and a single LC-MS DIA data set.
A direct comparison of precursor ion purity between the
diﬀerent data sets is diﬃcult as the score will vary considerably
based on the complexity of the sample, instrument used,
isolation window width, and the exact details of how the DDA
was performed (e.g., if blank exclusion was applied, length of
time on dynamic exclusion and number of MS2 scans per MS1
scan (top n method)). However, by using this wide range of
studies, a broad overview can be shown of the extent of
precursor ion purity in metabolomics.
For nearly all of the LC-MS DDA-based studies where the
isolation window width was ≤ ±1 Da, the median precursor
purity score was >0.7; the exception is study MTBLS214 where
the median precursor purity was 0.67. One factor contributing
to the lower score will be the larger number of consecutive MS2
scans (up to 26) being performed between MS1 scans, whereas
for all other DDA studies the maximum number of consecutive
MS2 scans was 12. The large number of MS2 scans acquired
consecutively can lead to lower intensity precursor ions selected
for fragmentation that would typically be ignored with a smaller
number of consecutive MS2 scans. This is demonstrated in
Figure 4C, where the purity of the MS2 spectra decreases with
the distance from the preceding MS1 scan. The study
MTBLS214 also highlighted the need for caution when the
number of consecutive MS2 scans is high. For this study, the
nearest MS1 scan used to calculate the purity score was up to
≈5.2 s (12 scans) away from the MS2 acquisition.
The precursor purity scores reported here are in general
agreement with the ﬁeld of proteomics, where the median
precursor purity score (or PIF, within this ﬁeld) of targeted
peptides was calculated as 0.85 and 0.73 for isolation windows
of ±0.5 Da and ±1 Da, respectively.16
Data were acquired in both positive and negative ionization
methods for 11 of the public data sets and allowed a
comparison between the precursor ion purity scores derived
from positive and negative methods. In general, the positive
ionization data had higher precursor purity scores than negative
ionization data (mean diﬀerence of +0.04), but this was not
always the case. For 7 out of the 11 data sets, the purity score
was signiﬁcantly higher for the positive ionization mode
(unpaired Wilcoxon rank sum adjusted p-value using Benjamini
& Hochberg approach < 0.0001), but for 3 out of the 11 data
sets, the purity score was signiﬁcantly smaller for the positive
ionization mode (unpaired Wilcoxon rank sum adjusted p-value
using Benjamini & Hochberg approach < 0.0001). See Table S2
for further details.
It should be noted that all of the scores presented in Figure 4
used the most intense peak within the isolation window for the
target precursor peak. When the peak that is at the center of the
isolation window is chosen for the calculation, then the
precursor purity scores were signiﬁcantly lower for all studies
(mean diﬀerence for all studies: −0.04, paired Wilcoxon rank
sum adjusted p-value using Benjamini & Hochberg approach <
0.0001). For the smaller isolation windows, the impact is
marginal, but for the larger isolation windows observed for DIA
experiments this has a much larger impact on the purity score T
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reported (−0.16 diﬀerence in purity). See Table S2 for full
details. The Raw Convertor23 tool also uses the most intense
peak in the isolation window as the precursor for the same
assumption used here; the most abundant peak within the
isolation window will contribute most to the fragmentation
spectra.
For the only public DIA data set available, the median purity
score is <0.1. The lower purity score for the DIA data set is
expected due to the much larger isolation window width. As the
principle behind DIA is to deconvolute spectra derived from
these large isolation windows, the purity score for DIA-based
data sets is in some regards inconsequential. Nevertheless, this
data set provides a good example to demonstrate that small
precursor ion purities are observed when very large isolation
window widths are employed.
For the one public DIMS DDA data set analyzed, the median
precursor purity score was 0.54. A lower precursor purity score
was expected due to the lack of chromatography and, therefore,
more complex MS1 scans as well as a longer period to acquire
MS2 spectra. This leads to a higher number of low intensity
precursor ions being fragmented that typically have lower
precursor purity scores. It should be acknowledged here that
the isobaric overlap from DIMS would also typically be higher
than LC-MS if no prior fractionation has been performed.
These assessments conﬁrm that the precursor ion purity
calculation can be performed on various types of MS2
experiment (DDA, DIA, LC-MS, and DIMS) from several
instrument manufactures (Thermo Scientiﬁc, AB Sciex, and
Agilent) and can provide a simple assessment of “chimeric”
spectra in a data set. If no deconvolution of the chimeric spectra
is to be performed, then spectra below a certain precursor
purity score can be removed to improve the accuracy of any
later spectral matching and annotation.
A plot of the intensity of the selected precursor ion against
the precursor purity shown in Figure 4B highlights a trend
where the most intense precursors will have higher purity
(closer to 1) but also shows that many precursors of lower
intensity can still have high purity scores. This implies that
simply having a higher threshold for the intensity of the
precursor ion to be chosen for fragmentation is insuﬃcient in
many cases to improve the precursor ion purity of MS2 spectra.
An acceptable level of precursor purity for DDA or targeted
analysis could be considered to be at a level at where spectral
matching to a library compound provides successful annotation
or identiﬁcation. In the ﬁeld of proteomics, when the precursor
purity score is at a relatively high level (≥0.5), the identiﬁcation
rate of proteins stays at nearly 60%.16 Similar rates are diﬃcult
to calculate for metabolomics data sets due to the lack of a
comprehensive database of metabolites and associated spectra.
However, it is reasonable to be cautious of any MS2 mass
spectra where the target precursor ion is thought to have
contributed less than half of the ions that have been
fragmented. We acknowledge though that the number of
other ions present in the isolation window, their relative
intensity compared to the chosen precursor ion, and the
complexity of the fragmentation mass spectra for each non-
precursor ion will also have a signiﬁcant contribution to the
ability to accurately apply the MS2 spectra for mass spectral
matching.
Assessing Precursor Purity of Anticipated MS2
Spectra. The anticipated precursor purity calculated for the
fwhm of the chromatographic peak for all XCMS features
(following blank subtraction) determined from two in-house
LC-MS data sets is summarized in Figure 5.
The complex D. magna sample consisting of 64,498 XCMS
features had a median purity score of 0.46. The less spectrally
complex sheep kidney (5071 XCMS features) had a median
precursor purity score of 0.66. The number of XCMS features
with anticipated precursor purity scores <0.5 was 53% for the
D. magna sample and 39% for the sheep kidney sample. If we
assume that reliable spectral matching requires a precursor
purity score >0.5, the results demonstrate there would be a
considerable number of XCMS features where the precursor
purity score is expected to be so low that it will be problematic
for standard MS2 spectral matching. If further MS2 experiments
were to be performed on a targeted group of these features, the
precursor purity score could then be used to direct the
acquisition of XCMS features where reliable MS2 matching
could be performed.
Validation of Anticipated Score of XCMS Feature. To
show how stable the anticipated precursor purity scores were
for the D. magna sample, an LC-MS2 DDA experiment was
conducted on the same data set as the original LC-MS
experiment. When there was an XCMS determined feature
observed between both the LC-MS and LC-MS2 data sets, it
allowed a comparison to be made of both the anticipated (i.e.,
predicted) precursor purity score and the precursor purity score
from the acquired MS2 data. A total of 2873 features were
assessed with a median of four MS2 spectra used for each
feature. The median diﬀerence between the anticipated and
observed precursor purity score was 0.05.
■ CONCLUSION
The msPurity package has been designed to evaluate precursor
purity or chimera in metabolomics MS2 data sets by calculating
an easily interpretable metric (intensity of selected precursor/
summed intensity of the isolation window) similar to the
previously described method used in proteomics.16 However,
the method described here diﬀers from the Michalski16
approach in that we interpolate peak intensity of MS2
Figure 5. Overview of the precursor purity of XCMS features
calculated for theoretical isolation windows of an anticipated MS2
experiment. Calculated for D. magna extracts (highly complex sample)
and sheep kidney extracts (less complex sample).
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acquisitions using bordering full-scan spectra, and we remove
low abundant peaks that are believed to have limited
contribution to resulting MS2 spectra and can optionally
remove isotopic peaks and take into account the isolation
eﬃciency of the mass spectrometer.
Using the msPurity package, we present here the ﬁrst
comprehensive characterization of precursor purity or chimera
in metabolomics and show that for complex samples a high
proportion of metabolite features will have low (<0.5)
precursor purity, which could be potentially problematic for
standard DDA-based spectral matching analysis.
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